Ekf Diagnostics Hold (EKDHF) 0.3559 $EKDHF
Global Rapid Medical Diagnostic Kits Market - Applications and Technologies Analysis of the $27 Billion Industry
M2 - Mon May 25, 10:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v48zr8/global_rapid) has announced the addition of the "Global Rapid Medical Diagnostic Kits Market - Applications and Technologies" report to their offering. lobal market for Rapid Medical Diagnostic Kits, estimated at US$19.4 billion in 2014, forecast at US$20.4 billion in 2015 and further expected to maintain a CAGR of 5.7% between 2014 and 2020 to reach a projected US$27 billion by 2020. The global market for Rapid Medical Diagnostic Kits (MDKs) has been witnessing steady, albeit not rapidly accelerated, growth over the past few years, and this trend is likely to sustain over the coming years. One of the major factors that can be attributed to this is the quick time, typically inside of 30 minutes, within which test results can be made available. This helps physicians in expediting the therapy process for individuals by prescribing the appropriate medications within a short period of time. Gone are the days when doctors had to rely on out-of-office laboratories, which more often than not took days, if not weeks, in processing and providing test results. Now, a clinical test using a sample from the patient can be performed within a physician's office, the specimen sent to an in-house laboratory and results obtained while the patient waits. Worldwide market for Rapid Medical Diagnostic Kits application segments explored in this study includes Clinical Testing, Home-Based Testing and Veterinary Testing. These broader application segments further analyzed for the applications areas of Blood Glucose, Cholesterol, Fertility & Pregnancy, Infectious Disease and Substance Abuse. The report also focuses on the technologies of Rapid Medical Diagnostic Kits comprising Agglutination, Flow-Through, Lateral Flow and Solid-Phase. The global markets for the above mentioned application segments and diagnostic technologies are analyzed in terms of USD. G This report reviews, analyses and projects the Rapid Medical Diagnostic Kits market for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 14 independent countries across North America - The United States, Canada and Mexico; Europe - France, Germany, Italy, Spain and the United Kingdom; Asia-Pacific -China, India, Japan and South Korea; South America - Argentina and Brazil. This report profiles 42 key global players and 55 major players across North America - 39; Europe - 7; and Asia-Pacific - 9. The research also provides the listing of the companies engaged in manufacturing and supply of Rapid MDKs. The global list of companies covers addresses, contact numbers and the website addresses of 193 companies. Key Topics Covered: Part A: Global Market Perspective 1. Introduction 2. Key Market Trends 3. Key Global Players 4. Key Business Trends 5. Global Market Overview Part B: Regional Market Perspective Regional Market Overview 1. North America 2. Europe 3. Asia-Pacific 4. South America 5. Rest Of World Part C: Guide To The Industry 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part
Annexure 1. Research Methodology 2. Feedback Companies Mentioned - Abbott Laboratories, Inc - Alfa Scientific Designs, Inc - Arkray USA Inc - Beckman Coulter Inc - Becton, Dickinson And Company - Biomerica, Inc - Biom?rieux SA - Bio-Rad Laboratories, Inc - Diagnostic Automation / Cortez Diagnostics Inc - EKF Diagnostics Holdings Plc - Enzo Life Sciences, Inc - F. Hoffmann-La Roche Ltd - IDEXX Laboratories, Inc - Immunostics, Inc - Inbios International, Inc - Jant Pharmacal Corporation - Labsystems Diagnostics OY - Lifescan, Inc - Princeton Biomeditech Corporation - Quidel Corporation - Rapid Diagnostic Pvt. Ltd - Roche Diagnostics Corporation - Runbio Biotech Co., Ltd. - SA Scientific, Inc - Sekisui Diagnostics, LLC - Shanghai Kehua Bio-Engineering Co., Ltd (KHB) - Siemens Healthcare - Standard Diagnostics, Inc - Taidoc Technology Corporation - Thermo Fisher Scientific Inc - Zoetis, Inc For more information visit http://www.researchandmarkets.com/research/v4...obal_rapid
ZTS: 46.96 (+0.39), ABT: 49.93 (+0.74), IDXX: 64.09 (+1.22)
Global Hemoglobin A1c Testing Devices (Laboratory Testing Devices & POC testing Devices) Market Analysis 2013-2019
M2 - Wed Sep 17, 3:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bjh9n8/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Testing Devices Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. 'Testing the levels of glycated hemoglobin provides an assurance to the healthcare practitioner about the patient's blood glucose level. This test can be used for diagnosis and monitoring of hemoglobin A1c levels in diabetic patients. Since A1C test reflects the average amount of glucose for the past 2 to 3 months, it is opined to be more reliable than conventional blood glucose test. Physicians are increasingly prescribing HbA1c test to their patients which will lead to an increase in the test volume. Moreover, rising diabetes incidence rate is a major driver for the HbA1c testing market. With growing awareness about prevention and management of diabetes, the demand for HbA1c testing devices will rise rapidly especially in the Asia-Pacific, Latin America, MiddleEast and African regions. Moreover, advent of these devices for the diagnosis of diabetes will further bolster the demand for these devices in future. For instance, approval for the COBAS INTEGRA 800 Tina-quant HbA1cDx assay, in 2013and Abbott's ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test approved in 2014 for the diagnosis of diabetes were the major steps in the hemoglobin A1c testing industry. With this diagnostic tools, physicians can combat the rising incidence of diabetes with timely and appropriate actions in identifying and managing diabetes. Based on the end-use, the global hemoglobin A1c testing devices market is categorized into two segments namely laboratory testing and point-of-care (POC) testing devices. Laboratory testing devices held the majority share of the market in 2012, while the global market for point-of-care testing devices is expected to grow at a faster paceduring the forecast period. Based on technologies, the hemoglobin A1c testing devices market is further categorized into five segments, namely, ion-exchange HPLC, immunoassay, boronate affinity chromatography, direct enzymatic assay and others. The boronate affinity chromatography market will be growing at a faster pace during the forecast period as this technology has no interference from hemoglobin variants and is also used in both laboratory as well as point-of-care testing. Healthcare practitioners are recommending the use of devices which offer least variant interference and this would elevate the demand for boronate affinity chromatography in HbA1c testing. The global hemoglobin A1c testing devices market is categorized into the following segments: Hemoglobin A1cTesting Devices Market, by End-use - Laboratory Testing Devices - Point-of-Care (POC)Testing Devices Hemoglobin A1cTesting Devices Market, by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC) - Immunoassay - Boronate Affinity Chromatography - Direct Enzymatic Assay - Others (Micro-Optical Detection Method and Capillary Electrophoresis) Key Topics Covered: - Introduction - Executive Summary - Global Hemoglobin A1c Testing Devices Market Overview - Global Hemoglobin A1c Testing Devices Market, by End-Use - Global Hemoglobin A1c Testing Devices Market, by Technology - Global Hemoglobin A1c Testing Devices Market, by Geography - Recommendations - Company Profiles - ARKRAY, Inc. - Abbott Laboratories - Alere, Inc. - Bio-Rad Laboratories, Inc. - Chek Diagnostics (Polymer Technology Systems, Inc.) - Danaher Corporation (Beckman Coulter) - EKF Diagnostics Holdings plc - F. Hoffmann-La Roche Ltd. - Menarini Group - Sebia - Siemens Healthcare - Tosoh Corporation - Trinity Biotech plc For more information visit http://www.researchandmarkets.com/research/bj...globin_a1c
ABT: 49.93 (+0.74), TRIB: 18.05 (+0.17), DHR: 86.65 (+0.91), ALR: 52.77 (+0.40)
Hemoglobin A1c Testing Devices Market Report 2013-2019: Overview, End-Use, Technology and Geographic Analysis
M2 - Wed Aug 06, 3:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5kcnsn/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global hemoglobin A1c testing devices market is characterized by the presence of some of the major companies including Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc. These players are seeking to develop HbA1c analyzers with quicker turnaround time, higher accuracy and reliable results. Moreover, approval of devices for diagnosis of diabetes has reinforced the development activities of these organizations to introduce products for rapid and early diagnosis. Moreover, advent of these devices for the diagnosis of diabetes will further bolster the demand for these devices in future. For instance, approval for the COBAS INTEGRA 800 Tina-quant HbA1cDx assay, in 2013 and Abbott's ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test approved in 2014 for the diagnosis of diabetes were the major steps in the hemoglobin A1c testing industry. With this diagnostic tools, physicians can combat the rising incidence of diabetes with timely and appropriate actions in identifying and managing diabetes. Based on the end-use, the global hemoglobin A1c testing devices market is categorized into two segments namely laboratory testing and point-of-care (POC) testing devices. Laboratory testing devices held the majority share of the market in 2012, while the global market for point-of-care testing devices is expected to grow at a faster pace during the forecast period. Based on technologies, the hemoglobin A1c testing devices market is further categorized into five segments, namely, ion-exchange HPLC, immunoassay, boronate affinity chromatography, direct enzymatic assay and others. The boronate affinity chromatography market will be growing at a faster pace during the forecast period as this technology has no interference from hemoglobin variants and is also used in both laboratory as well as point-of-care testing. Healthcare practitioners are recommending the use of devices which offer least variant interference and this would elevate the demand for boronate affinity chromatography in HbA1c testing. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Hemoglobin A1c Testing Devices Market Overview Chapter 4 Global Hemoglobin A1c Testing Devices Market, by End-Use Chapter 5 Global Hemoglobin A1c Testing Devices Market, by Technology Chapter 6 Global Hemoglobin A1c Testing Devices Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles - Abbott Laboratories - Alere, Inc. - ARKRAY, Inc. - Bio-Rad Laboratories, Inc. - Chek Diagnostics (Polymer Technology Systems, Inc.) - Danaher Corporation (Beckman Coulter) - EKF Diagnostics Holdings plc - F. Hoffmann-La Roche Ltd. - Menarini Group - Sebia - Siemens Healthcare - Tosoh Corporation - Trinity Biotech plc For more information visit http://www.researchandmarkets.com/research/5k...globin_a1c
ABT: 49.93 (+0.74), TRIB: 18.05 (+0.17), DHR: 86.65 (+0.91), ALR: 52.77 (+0.40)
Hemoglobin A1c Testing Devices Market Forecasts and Opportunities, 2019
M2 - Tue Jul 22, 2:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v5x4hl/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Testing Devices Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. This study covers the market analysis for various technologies and end-uses of hemoglobin A1c (HbA1c) testing devices. The stakeholders for this report include manufacturers of hemoglobin A1C testing analyzers and research organizations involved in developing new and innovative technologies for hemoglobin A1c testing. The market overview section of this report gives a detailed description about the market dynamics and trends including drivers, restraints and opportunities that influence the current and future scenario of this market. This section also covers market attractiveness analysis and Porter's five forces analysis to give an understanding about the competitive scenario of global hemoglobin A1C testing devices market. The global hemoglobin A1c testing devices market is analyzed on the basis of technologies and end-uses hemoglobin A1c testing. With respect to technologies, this study considers five testing categories, namely, immunoassays, ion-exchange high performance liquid chromatography (HPLC), direct enzymatic assay, boronate affinity chromatography and others (micro-optical detection method and capillary electrophoresis). Based on the end-uses, this market is categorized into laboratory testing and point-of-care (POC) testing segments. With respect to geographical distribution, the global hemoglobin A1C testing devices market has been classified into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). This section of report provides market size (for the period 2011 - 2019) and forecast (for the period 2013 - 2019) for each regional market in terms of USD million. The report further provides strategic recommendations, which would be helpful for the current market players and the new entrants to grow in the hemoglobin A1c testing devices market. Report Scope Hemoglobin A1cTesting Devices Market, by End-use - Laboratory Testing Devices - Point-of-Care (POC)Testing Devices Hemoglobin A1cTesting Devices Market, by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC) - Immunoassay - Boronate Affinity Chromatography - Direct Enzymatic Assay - Others (Micro-Optical Detection Method and Capillary Electrophoresis) Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Hemoglobin A1c Testing Devices Market Overview Chapter 4 Global Hemoglobin A1c Testing Devices Market, by End-Use Chapter 5 Global Hemoglobin A1c Testing Devices Market, by Technology Chapter 6 Global Hemoglobin A1c Testing Devices Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles - ARKRAY, Inc. - Abbott Laboratories - Alere, Inc. - Bio-Rad Laboratories, Inc. - Chek Diagnostics (Polymer Technology Systems, Inc.) - Danaher Corporation (Beckman Coulter) - EKF Diagnostics Holdings plc - F. Hoffmann-La Roche Ltd. - Menarini Group - Sebia - Siemens Healthcare - Tosoh Corporation - Trinity Biotech plc For more information visit http://www.researchandmarkets.com/research/v5...globin_a1c
ABT: 49.93 (+0.74), TRIB: 18.05 (+0.17), DHR: 86.65 (+0.91), ALR: 52.77 (+0.40)
Global Rapid Medical Diagnostic Kits Market - Applications and Technologies Analysis of the $27 Billion Industry
M2 - Mon May 25, 10:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v48zr8/global_rapid) has announced the addition of the "Global Rapid Medical Diagnostic Kits Market - Applications and Technologies" report to their offering. lobal market for Rapid Medical Diagnostic Kits, estimated at US$19.4 billion in 2014, forecast at US$20.4 billion in 2015 and further expected to maintain a CAGR of 5.7% between 2014 and 2020 to reach a projected US$27 billion by 2020. The global market for Rapid Medical Diagnostic Kits (MDKs) has been witnessing steady, albeit not rapidly accelerated, growth over the past few years, and this trend is likely to sustain over the coming years. One of the major factors that can be attributed to this is the quick time, typically inside of 30 minutes, within which test results can be made available. This helps physicians in expediting the therapy process for individuals by prescribing the appropriate medications within a short period of time. Gone are the days when doctors had to rely on out-of-office laboratories, which more often than not took days, if not weeks, in processing and providing test results. Now, a clinical test using a sample from the patient can be performed within a physician's office, the specimen sent to an in-house laboratory and results obtained while the patient waits. Worldwide market for Rapid Medical Diagnostic Kits application segments explored in this study includes Clinical Testing, Home-Based Testing and Veterinary Testing. These broader application segments further analyzed for the applications areas of Blood Glucose, Cholesterol, Fertility & Pregnancy, Infectious Disease and Substance Abuse. The report also focuses on the technologies of Rapid Medical Diagnostic Kits comprising Agglutination, Flow-Through, Lateral Flow and Solid-Phase. The global markets for the above mentioned application segments and diagnostic technologies are analyzed in terms of USD. G This report reviews, analyses and projects the Rapid Medical Diagnostic Kits market for global and the regional markets including North America, Europe, Asia-Pacific, South America and Rest of World. The regional markets further analyzed for 14 independent countries across North America - The United States, Canada and Mexico; Europe - France, Germany, Italy, Spain and the United Kingdom; Asia-Pacific -China, India, Japan and South Korea; South America - Argentina and Brazil. This report profiles 42 key global players and 55 major players across North America - 39; Europe - 7; and Asia-Pacific - 9. The research also provides the listing of the companies engaged in manufacturing and supply of Rapid MDKs. The global list of companies covers addresses, contact numbers and the website addresses of 193 companies. Key Topics Covered: Part A: Global Market Perspective 1. Introduction 2. Key Market Trends 3. Key Global Players 4. Key Business Trends 5. Global Market Overview Part B: Regional Market Perspective Regional Market Overview 1. North America 2. Europe 3. Asia-Pacific 4. South America 5. Rest Of World Part C: Guide To The Industry 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part
Annexure 1. Research Methodology 2. Feedback Companies Mentioned - Abbott Laboratories, Inc - Alfa Scientific Designs, Inc - Arkray USA Inc - Beckman Coulter Inc - Becton, Dickinson And Company - Biomerica, Inc - Biom?rieux SA - Bio-Rad Laboratories, Inc - Diagnostic Automation / Cortez Diagnostics Inc - EKF Diagnostics Holdings Plc - Enzo Life Sciences, Inc - F. Hoffmann-La Roche Ltd - IDEXX Laboratories, Inc - Immunostics, Inc - Inbios International, Inc - Jant Pharmacal Corporation - Labsystems Diagnostics OY - Lifescan, Inc - Princeton Biomeditech Corporation - Quidel Corporation - Rapid Diagnostic Pvt. Ltd - Roche Diagnostics Corporation - Runbio Biotech Co., Ltd. - SA Scientific, Inc - Sekisui Diagnostics, LLC - Shanghai Kehua Bio-Engineering Co., Ltd (KHB) - Siemens Healthcare - Standard Diagnostics, Inc - Taidoc Technology Corporation - Thermo Fisher Scientific Inc - Zoetis, Inc For more information visit http://www.researchandmarkets.com/research/v4...obal_rapid ZTS: 46.96 (+0.39), ABT: 49.93 (+0.74), IDXX: 64.09 (+1.22)
Global Hemoglobin A1c Testing Devices (Laboratory Testing Devices & POC testing Devices) Market Analysis 2013-2019
M2 - Wed Sep 17, 3:52AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bjh9n8/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Testing Devices Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. 'Testing the levels of glycated hemoglobin provides an assurance to the healthcare practitioner about the patient's blood glucose level. This test can be used for diagnosis and monitoring of hemoglobin A1c levels in diabetic patients. Since A1C test reflects the average amount of glucose for the past 2 to 3 months, it is opined to be more reliable than conventional blood glucose test. Physicians are increasingly prescribing HbA1c test to their patients which will lead to an increase in the test volume. Moreover, rising diabetes incidence rate is a major driver for the HbA1c testing market. With growing awareness about prevention and management of diabetes, the demand for HbA1c testing devices will rise rapidly especially in the Asia-Pacific, Latin America, MiddleEast and African regions. Moreover, advent of these devices for the diagnosis of diabetes will further bolster the demand for these devices in future. For instance, approval for the COBAS INTEGRA 800 Tina-quant HbA1cDx assay, in 2013and Abbott's ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test approved in 2014 for the diagnosis of diabetes were the major steps in the hemoglobin A1c testing industry. With this diagnostic tools, physicians can combat the rising incidence of diabetes with timely and appropriate actions in identifying and managing diabetes. Based on the end-use, the global hemoglobin A1c testing devices market is categorized into two segments namely laboratory testing and point-of-care (POC) testing devices. Laboratory testing devices held the majority share of the market in 2012, while the global market for point-of-care testing devices is expected to grow at a faster paceduring the forecast period. Based on technologies, the hemoglobin A1c testing devices market is further categorized into five segments, namely, ion-exchange HPLC, immunoassay, boronate affinity chromatography, direct enzymatic assay and others. The boronate affinity chromatography market will be growing at a faster pace during the forecast period as this technology has no interference from hemoglobin variants and is also used in both laboratory as well as point-of-care testing. Healthcare practitioners are recommending the use of devices which offer least variant interference and this would elevate the demand for boronate affinity chromatography in HbA1c testing. The global hemoglobin A1c testing devices market is categorized into the following segments: Hemoglobin A1cTesting Devices Market, by End-use - Laboratory Testing Devices - Point-of-Care (POC)Testing Devices Hemoglobin A1cTesting Devices Market, by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC) - Immunoassay - Boronate Affinity Chromatography - Direct Enzymatic Assay - Others (Micro-Optical Detection Method and Capillary Electrophoresis) Key Topics Covered: - Introduction - Executive Summary - Global Hemoglobin A1c Testing Devices Market Overview - Global Hemoglobin A1c Testing Devices Market, by End-Use - Global Hemoglobin A1c Testing Devices Market, by Technology - Global Hemoglobin A1c Testing Devices Market, by Geography - Recommendations - Company Profiles - ARKRAY, Inc. - Abbott Laboratories - Alere, Inc. - Bio-Rad Laboratories, Inc. - Chek Diagnostics (Polymer Technology Systems, Inc.) - Danaher Corporation (Beckman Coulter) - EKF Diagnostics Holdings plc - F. Hoffmann-La Roche Ltd. - Menarini Group - Sebia - Siemens Healthcare - Tosoh Corporation - Trinity Biotech plc For more information visit http://www.researchandmarkets.com/research/bj...globin_a1c
ABT: 49.93 (+0.74), TRIB: 18.05 (+0.17), DHR: 86.65 (+0.91), ALR: 52.77 (+0.40)
Hemoglobin A1c Testing Devices Market Report 2013-2019: Overview, End-Use, Technology and Geographic Analysis
M2 - Wed Aug 06, 3:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5kcnsn/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. The global hemoglobin A1c testing devices market is characterized by the presence of some of the major companies including Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare and Trinity Biotech plc. These players are seeking to develop HbA1c analyzers with quicker turnaround time, higher accuracy and reliable results. Moreover, approval of devices for diagnosis of diabetes has reinforced the development activities of these organizations to introduce products for rapid and early diagnosis. Moreover, advent of these devices for the diagnosis of diabetes will further bolster the demand for these devices in future. For instance, approval for the COBAS INTEGRA 800 Tina-quant HbA1cDx assay, in 2013 and Abbott's ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test approved in 2014 for the diagnosis of diabetes were the major steps in the hemoglobin A1c testing industry. With this diagnostic tools, physicians can combat the rising incidence of diabetes with timely and appropriate actions in identifying and managing diabetes. Based on the end-use, the global hemoglobin A1c testing devices market is categorized into two segments namely laboratory testing and point-of-care (POC) testing devices. Laboratory testing devices held the majority share of the market in 2012, while the global market for point-of-care testing devices is expected to grow at a faster pace during the forecast period. Based on technologies, the hemoglobin A1c testing devices market is further categorized into five segments, namely, ion-exchange HPLC, immunoassay, boronate affinity chromatography, direct enzymatic assay and others. The boronate affinity chromatography market will be growing at a faster pace during the forecast period as this technology has no interference from hemoglobin variants and is also used in both laboratory as well as point-of-care testing. Healthcare practitioners are recommending the use of devices which offer least variant interference and this would elevate the demand for boronate affinity chromatography in HbA1c testing. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Hemoglobin A1c Testing Devices Market Overview Chapter 4 Global Hemoglobin A1c Testing Devices Market, by End-Use Chapter 5 Global Hemoglobin A1c Testing Devices Market, by Technology Chapter 6 Global Hemoglobin A1c Testing Devices Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles - Abbott Laboratories - Alere, Inc. - ARKRAY, Inc. - Bio-Rad Laboratories, Inc. - Chek Diagnostics (Polymer Technology Systems, Inc.) - Danaher Corporation (Beckman Coulter) - EKF Diagnostics Holdings plc - F. Hoffmann-La Roche Ltd. - Menarini Group - Sebia - Siemens Healthcare - Tosoh Corporation - Trinity Biotech plc For more information visit http://www.researchandmarkets.com/research/5k...globin_a1c
ABT: 49.93 (+0.74), TRIB: 18.05 (+0.17), DHR: 86.65 (+0.91), ALR: 52.77 (+0.40)
Hemoglobin A1c Testing Devices Market Forecasts and Opportunities, 2019
M2 - Tue Jul 22, 2:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v5x4hl/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Testing Devices Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. This study covers the market analysis for various technologies and end-uses of hemoglobin A1c (HbA1c) testing devices. The stakeholders for this report include manufacturers of hemoglobin A1C testing analyzers and research organizations involved in developing new and innovative technologies for hemoglobin A1c testing. The market overview section of this report gives a detailed description about the market dynamics and trends including drivers, restraints and opportunities that influence the current and future scenario of this market. This section also covers market attractiveness analysis and Porter's five forces analysis to give an understanding about the competitive scenario of global hemoglobin A1C testing devices market. The global hemoglobin A1c testing devices market is analyzed on the basis of technologies and end-uses hemoglobin A1c testing. With respect to technologies, this study considers five testing categories, namely, immunoassays, ion-exchange high performance liquid chromatography (HPLC), direct enzymatic assay, boronate affinity chromatography and others (micro-optical detection method and capillary electrophoresis). Based on the end-uses, this market is categorized into laboratory testing and point-of-care (POC) testing segments. With respect to geographical distribution, the global hemoglobin A1C testing devices market has been classified into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). This section of report provides market size (for the period 2011 - 2019) and forecast (for the period 2013 - 2019) for each regional market in terms of USD million. The report further provides strategic recommendations, which would be helpful for the current market players and the new entrants to grow in the hemoglobin A1c testing devices market. Report Scope Hemoglobin A1cTesting Devices Market, by End-use - Laboratory Testing Devices - Point-of-Care (POC)Testing Devices Hemoglobin A1cTesting Devices Market, by Technology - Ion-Exchange High Performance Liquid Chromatography (HPLC) - Immunoassay - Boronate Affinity Chromatography - Direct Enzymatic Assay - Others (Micro-Optical Detection Method and Capillary Electrophoresis) Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Hemoglobin A1c Testing Devices Market Overview Chapter 4 Global Hemoglobin A1c Testing Devices Market, by End-Use Chapter 5 Global Hemoglobin A1c Testing Devices Market, by Technology Chapter 6 Global Hemoglobin A1c Testing Devices Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles - ARKRAY, Inc. - Abbott Laboratories - Alere, Inc. - Bio-Rad Laboratories, Inc. - Chek Diagnostics (Polymer Technology Systems, Inc.) - Danaher Corporation (Beckman Coulter) - EKF Diagnostics Holdings plc - F. Hoffmann-La Roche Ltd. - Menarini Group - Sebia - Siemens Healthcare - Tosoh Corporation - Trinity Biotech plc For more information visit http://www.researchandmarkets.com/research/v5...globin_a1c
ABT: 49.93 (+0.74), TRIB: 18.05 (+0.17), DHR: 86.65 (+0.91), ALR: 52.77 (+0.40)
